LIfT BioSciences

Biotech & Life Sciences · London, United Kingdom · Founded 2016

Lift Biosciences is a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy MoreLess

LIfT Biosciences® has a breakthrough allogeneic innate immuno-cell therapy platform called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) that allows us to produce different types of Immunomodulatory Alpha Neutrophils (IMAN®s) at scale from iPSCs for a wide range of different purposes as a mono or combo.

Valuation $0–100M

Headcount <100

Total funding $10–50M

Unlock exact values

Company overview

LIfT BioSciences company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2016
Headquarters: London, United Kingdom
Employees: 22
Open positions: None listed
Dealroom signal: 81.8

Website ↗LinkedIn ↗X ↗

client focusb2bsub industryPharmaceuticalsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorOncologysectorResearch and DevelopmentsectorEuropean Health Catapult (EIT Health)sectorEuropean Health Catapult 2018 (EIT Health)sectorClinical TrialssectorBiotech and PharmasectorEIT HealthsectorHard Tech

Valuation & funding

LIfT BioSciences funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANT✓Other financing	Jul 2025	$13M	—	Disruptive Technologies Innovation Fund	↗
SERIES A✓Equity / VC	Sep 2024	$13M	$53M	Starbloom Capital · LifeSpan Vision Ventures · Jonathan Milner · Sijbrandij Foundation	↗
GRANTOther financing	May 2024	$1.3M	—	Undisclosed	↗
OtherOther financing	Dec 2022	$0	—	Undisclosed	↗
SEED✓Equity / VC	Jan 2020	$713K	$13M	Undisclosed	—
SEED✓Equity / VC	Aug 2019			Shadow Foundr	—
SUPPORT PROGRAM✓Other financing	Oct 2018			EIT Health	—
SEED✓Equity / VC	Mar 2018			Undisclosed	—

Showing 8 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

Year	Employees
2026	22
2025	22
2024	24
2023	18
2022	15
2021	6

Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

LIfT BioSciences website traffic

Latest recorded traffic for LIfT BioSciences is 1.7K monthly website visits, up 0% over the last three months. LIfT BioSciences's team grew 0% over the past year.

Latest monthly visits1.7K 3-month web change0% 1-year team growth0%

Monthly website visits76 observations · Oct 2018–Jul 2026

Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

LIfT BioSciences compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OBOchre BioDevelops RNA therapies for chronic liver diseases, a leading cause of death globally	Oxford, United Kingdom	Operational	62	$40M	$120M
ZHZio HealthPocket-sized biosensor technology for point-of-care molecular testing	London, United Kingdom	Operational
SBSixfold BioscienceAI-powered programmable RNA delivery system for therapeutics.	London, United Kingdom	Operational
LHLindus HealthAccelerates clinical trials for biotech and healthtech pioneers	London, United Kingdom	Operational
OPOptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management	Oxford, United Kingdom	Operational
ILiLoFAI and photonics platform for personalized drug discovery.	London, United Kingdom	Operational
PHPharmaforesight.aiDeveloped a powerful machine learning algorithm that can predict the probability of success of a trial, before it has even started	London, United Kingdom	Operational
SISmart ImmuneDevelops off-the-shelf allogeneic T-cell progenitor therapies to restore a fully functional immune system in patients with cancer and severe infections	Paris, France	Operational

Showing 8 of the closest matchesCompare every metric →

Talent graph

LIfT BioSciences's talent

Book a demo to see the people

Team profiled 8 named & role-tagged

Founders /100 quality score

Key operators 1 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on LIfT BioSciences's cap table

Sourced from Dealroom's funding and investor records.

Seed 2 investors entered at this stage

Shadow Foundr

Disruptive Technologies Innovation Fund

Series A 4 investors entered at this stage

Starbloom Capital

LifeSpan Vision Ventures

Jonathan Milner

Sijbrandij Foundation

Other known 4 additional known investors

EIT Health

Grow London

London BioScience Innovation Centre

MassChallenge

Global footprint

Where LIfT BioSciences has talent and traffic

Workforce by country

2 countries with
team presence

🇬🇧 United Kingdom76.9%

🇺🇸 United States23.1%

2 countries shown

In the news

Latest news about LIfT BioSciences

Recent press, funding announcements, and product moves mentioning LIfT BioSciences — open to read from the original sources.

See all news

Market sentiment

What the market is saying about LIfT BioSciences

An AI-synthesized read of the highest-engagement posts about LIfT BioSciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See LIfT BioSciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.